Innoscience Europe
The computed 12-month bankruptcy probability of Innoscience Europe is 1.0% (low). The 2024 annual accounts show equity of €672k and a net result of €90k. Equity is growing by ~15.4% per year across the filed fiscal years. Its solvency ranks better than 77% of 220 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €672k |
| Net result | €90k |
| Staff (FTE) | 6 |
| Better than sector | 77% |
Exceptional profile, strong across almost every axis.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 74.4% | 46.7% | |
| Net result | €90k | €31k | |
| Equity | €672k | €133k | |
| Gross operating margin | €1.52M | €71k | |
| Staff costs | €1.37M | €200k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €152k |
| Net profit | €90k |
| Cash flow | €110k |
| Staff costs | €1.37M |
| Income taxes | €41k |
| Dividends | - |
| Total assets | €903k |
| Equity | €672k |
| Debt | €231k |
| of which ≤ 1y | €231k |
| of which > 1y | - |
| Working capital | €592k |
| Employees (FTE) | 6.0 |
| 2024 | |
|---|---|
| Current ratio | 3.57 |
| Quick ratio | 3.57 |
| Working capital ratio | 65.6% |
| Solvency | 74.4% |
| Debt / equity | 0.34 |
| Long-term debt ratio | - |
| Interest coverage | 72.86 |
| Gross margin | - |
| Net margin | - |
| ROA | 10.0% |
| ROE | 13.4% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €903k |
| Fixed assets | 21/28 | €79k |
| Tangible fixed assets | 22/27 | €60k |
| Financial fixed assets | 28 | €19k |
| Current assets | 29/58 | €823k |
| Amounts receivable within one year | 40/41 | €373k |
| Cash & bank | 54/58 | €405k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €903k |
| Equity | 10/15 | €672k |
| Contributions / capital | 10/11 | €400k |
| Reserves | 13 | €272k |
| Amounts payable | 17/49 | €231k |
| Amounts payable within one year | 42/48 | €231k |
| Trade debts payable within one year | 44 | €51k |
| Income statement | ||
| Gross operating margin | 9900 | €1.52M |
| Operating result | 9901 | €133k |
| Financial income | 75 | €34 |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €131k |
| Income taxes | 67/77 | €41k |
| Net result for the period | 9904 | €90k |
| Result to be appropriated | 9905 | €90k |
-
Current10-11-2021 → present
Former directors (2)
-
Former10-11-2021 → 08-12-2025
2 events
- 08-12-2025 Resigned· Director
- 10-11-2021 Appointed· Director
-
Former10-11-2021 → 22-11-2023
2 events
- 22-11-2023 Resigned· Director
- 10-11-2021 Appointed· Director
| NACE primary | Advertising & market research(73200) |
| Legal form | Public limited company(014) |
| Incorporation | 21-10-2021 |
| Status | Active |
| Postal code | 3001 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24433E0025/00C002 | Flanders | 6,606 m² | 1 · 2,027 m² | 32.0 m · 9 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
27-03-2026 General meeting · Officer resignation · Power of attorney
- Publication: 27/03/2026 · Innoscience Europe
- Filing: 19/03/2026 · Innoscience Europe
- General meeting: 08/12/2025 · Innoscience Europe
- Officer resignation: role: bestuurder, end_date: 2025-12-08 · DIANQUAN JIAO
- Power of attorney: uitvoeren van alle (rechts)handelingen of formaliteiten die nuttig en/of noodzakelijk zijn om de neerlegging te verzorgen van alle formaliteiten, akten, stukken, notulen, beslissingen waarvoor volgens het Wetboek van vennootschappen en verenigingen een neerlegging in het vennootschapsdossier en/of een publicatie in (de bijlagen bij) het Belgisch Staatsblad is vereist · Xerius Contact VZW
Technical details
{
"facts": [
{
"date": "2026-03-27",
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 27/03/2026",
"value": "27/03/2026",
"object": null,
"subject": "e1"
},
{
"date": "2026-03-19",
"type": "filing",
"quote": "ONDERNEMINGSRECHTBANK 19 MAART 2026",
"value": "19/03/2026",
"object": null,
"subject": "e1"
},
{
"date": "2025-12-08",
"type": "general_meeting",
"quote": "Uittreksel uit de notulen van de bijz\u00F3ndere algemene vergadering dd. 08/12/2025",
"value": "08/12/2025",
"object": null,
"subject": "e1"
},
{
"type": "officer_resignation",
"quote": "De vergadering beslist met eenparigheid van stemmen om per 08 december 2025 de heer DIANQUAN JIAO ... te ontslagen als bestuurder.",
"value": {
"role": "bestuurder",
"end_date": "2025-12-08"
},
"object": "e1",
"subject": "e2",
"_value_raw": {
"role": "bestuurder",
"end_date": "08/12/2025"
}
},
{
"type": "power_of_attorney",
"quote": "Bijzondere volmacht wordt verleend aan Xerius Contact VZW ... om in naam en voor rekening van de Lastgever over te gaan tot het uitvoeren van alle (rechts)handelingen of formaliteiten die nuttig en/of noodzakelijk zijn om de neerlegging te verzorgen van alle formaliteiten, akten, stukken, notulen, beslissingen waarvoor volgens het Wetboek van vennootschappen en verenigingen een neerlegging in het vennootschapsdossier en/of een publicatie in (de bijlagen bij) het Belgisch Staatsblad is vereist",
"value": "uitvoeren van alle (rechts)handelingen of formaliteiten die nuttig en/of noodzakelijk zijn om de neerlegging te verzorgen van alle formaliteiten, akten, stukken, notulen, beslissingen waarvoor volgens het Wetboek van vennootschappen en verenigingen een neerlegging in het vennootschapsdossier en/of een publicatie in (de bijlagen bij) het Belgisch Staatsblad is vereist",
"object": "e1",
"subject": "e3"
}
],
"act_meta": {
"outcome": "clean",
"model_id": 50,
"verified": true,
"extractor": "verified-v1",
"ocr_chars": 2319,
"truncated": false
},
"entities": [
{
"id": "e1",
"kbo": "0775.996.337",
"kind": "company",
"name": "Innoscience Europe",
"attrs": {}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "DIANQUAN JIAO",
"attrs": {}
},
{
"id": "e3",
"kbo": "0410.958.217",
"kind": "org",
"name": "Xerius Contact VZW",
"attrs": {}
}
]
}25-04-2024 RUILI XIAO resigns as director
- RUILI XIAO, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "RUILI XIAO",
"address": null,
"birth_date": null
},
"effective_date": "2023-11-22",
"evidence_quote": "De vergadering beslist met eenparigheid van stemmen om per 22 november 2023 mevrouw RUILI XIAO, woonst kiezend op de zetel van de vennootschap, te ontslagen als bestuurder."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0775.996.337",
"name_full": "INNOSCIENCE EUROPE",
"legal_form": "NV"
}
}29-09-2022 Capital increase of €338,500 to €400,000
- €61.500 → €400.000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 338500.0,
"currency": "EUR",
"after_eur": 400000.0,
"delta_eur": 338500.0,
"before_eur": 61500.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-09-22",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 338.500,00 EUR, om het van 61.500,00 EUR te brengen op 400.000,00 EUR, door uitgifte van 1.000 aandelen van dezelfde aard en die dezelfde rechten en voordelen zullen bieden als de bestaande aandelen, en die in de winsten zullen delen pro rata temporis vanaf de inschrijving. De vergadering beslist dat de kapitaalverhoging zal worden verwezenlijkt door de inbreng door de vennootschap naar het recht van de Verenigde Staten \u0022Innoscience America, Inc.\u0022, van een zekere, vaststaande en opeisbare schuldvordering die zij heeft ten laste van de Vennootschap en welke uitvoerig beschreven staat in voormelde verslagen.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0775.996.337",
"name_full": "INNOSCIENCE EUROPE",
"legal_form": "NV"
}
}24-12-2021 3 directors appointed
- JIAO DIANQUAN, Bestuurder
- XIAO RUILI, Bestuurder
- MARCON DENIS, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "JIAO DIANQUAN",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-10",
"evidence_quote": "De vergadering beslist met eenparigheid van stemmen om per 10 november 2021 als bijkomende bestuurders te benoemen de heer JIAO DIANQUAN en mevrouw RUILI XIAO beide woonst kiezend op de zetel van de vennootschap."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "XIAO RUILI",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-10",
"evidence_quote": "De vergadering beslist met eenparigheid van stemmen om per 10 november 2021 als bijkomende bestuurders te benoemen de heer JIAO DIANQUAN en mevrouw RUILI XIAO beide woonst kiezend op de zetel van de vennootschap."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "MARCON DENIS",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-10",
"evidence_quote": "Conform artikel 10, tweede alinea, van de statuten van de vennootschap beslist de raad van bestuur. onmiddellijk na zijn aanstelling als bestuurder, de heer Denis Marcon, keuze van woonstplaats doende op de zetel van de vennootschap, te benoemen als gedelegeerd bestuurder."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0775.996.337",
"name_full": "INNOSCIENCE EUROPE",
"legal_form": "NV"
}
}25-10-2021 Incorporation of a new NV
Technical details
{
"kind": "oprichting",
"seat": "3001 Leuven, Philipssite 5 bus 1",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0775.806.592",
"name": "Innoscience America, Inc."
},
"kind": "rechtspersoon",
"person": null,
"share_class": "naamloze aandelen",
"partner_role": null,
"holder_org_kbo": "0775.806.592",
"holder_org_name": "Innoscience America, Inc.",
"contribution_type": "cash",
"amount_paid_in_eur": 61500,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1000,
"amount_subscribed_eur": 61500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 61500,
"subject_company": {
"kbo": "0775.996.337",
"name_full": "Innoscience Europe",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2021-10-21",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Innoscience Europe |